T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Zeta Global
ZETA
$7.11B
| $58.3M | 0.01% |
3,302,670
+3,211,475
| +3,522% | +$47.1M |
|
677
Huntsman Corp
HUN
$1.81B
| $58M | 0.01% |
2,548,496
+139,904
| +6% | +$3.41M |
|
678
CBIZ
CBZ
$2.96B
| $57.6M | 0.01% |
777,569
-50,630
| -6% | -$3.83M |
|
679
Tenaris
TS
$26.7B
| $57.3M | 0.01% |
1,876,865
+94,136
| +5% | +$3.26M |
|
680
Natera
NTRA
$44.9B
| $57.3M | 0.01% |
528,810
-141,151
| -21% | -$14.3M |
|
|
NUVL
681
DELISTED
Nuvalent
NUVL
| $57.2M | 0.01% |
754,138
-104,023
| -12% | -$7.4M |
|
682
Iron Mountain
IRM
$37.6B
| $56.7M | 0.01% |
632,826
+40,053
| +7% | +$3.24M |
|
683
CorVel
CRVL
$3.21B
| $56.1M | 0.01% |
662,079
+13,116
| +2% | +$1.08M |
|
684
10x Genomics
TXG
$7.61B
| $55.9M | 0.01% |
2,873,952
-783,275
| -21% | -$20.5M |
|
685
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.67B
| $55.9M | 0.01% |
384,168
-1,170
| -0.3% | -$177K |
|
686
Nexstar Media Group
NXST
$5.75B
| $55.9M | 0.01% |
336,580
-77,787
| -19% | -$12.6M |
|
687
Aptiv
APTV
$10B
| $55.7M | 0.01% |
790,622
-959,611
| -55% | -$73.8M |
|
|
EDR
688
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $55.5M | 0.01% |
2,053,001
-620,607
| -23% | -$16.5M |
|
689
Brown & Brown
BRO
$23.7B
| $55.4M | 0.01% |
619,589
+226,317
| +58% | +$19.6M |
|
690
W.W. Grainger
GWW
$61.9B
| $55.2M | 0.01% |
61,230
+1,242
| +2% | +$1.17M |
|
691
Crane Co
CR
$12.8B
| $55.1M | 0.01% |
379,923
+354,754
| +1,409% | +$50.3M |
|
692
Healthcare Realty
HR
$6.6B
| $54.9M | 0.01% |
3,333,590
-2,448,663
| -42% | -$37.5M |
|
693
Xylem
XYL
$28.2B
| $54.9M | 0.01% |
404,897
+79,401
| +24% | +$10.8M |
|
694
Emcor
EME
$37.1B
| $54.8M | 0.01% |
150,115
+5,314
| +4% | +$1.96M |
|
695
Affirm
AFRM
$25.9B
| $54.7M | 0.01% |
1,810,717
-344,282
| -16% | -$11M |
|
696
Corteva
CTVA
$50.2B
| $54.3M | 0.01% |
1,007,265
+23,349
| +2% | +$1.29M |
|
697
Keros Therapeutics
KROS
$216M
| $54.3M | 0.01% |
1,187,910
-30,594
| -3% | -$1.64M |
|
698
Loar Holdings
LOAR
$6.91B
| $54.2M | 0.01% |
+1,015,413
| New | +$55M |
|
|
CSW
699
CSW Industrials
CSW
$5.6B
| $54.1M | 0.01% |
203,974
+574
| +0.3% | +$142K |
|
700
American Water Works
AWK
$27.1B
| $53.9M | 0.01% |
417,665
-15,256
| -4% | -$1.93M |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.